Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy ESSA Pharma stock

Own ESSA Pharma stock in just a few minutes.

ESSA Pharma Inc is a biotechnology business based in the US. ESSA Pharma shares (EPIX) are listed on the NASDAQ and all prices are listed in US Dollars. ESSA Pharma employs 25 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in ESSA Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EPIX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

ESSA Pharma share price

Use our graph to track the performance of EPIX stocks over time.

ESSA Pharma shares at a glance

Information last updated 2021-04-30.
52-week range$4.26 - $32.65
50-day moving average $28.89
200-day moving average $17.13
Wall St. target price$0.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.75

Buy ESSA Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ESSA Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ESSA Pharma financials

Gross profit TTM $0
Return on assets TTM -25.79%
Return on equity TTM -42.22%
Profit margin 0%
Book value $2.21
Market capitalisation $1.2 billion

TTM: trailing 12 months

Shorting ESSA Pharma shares

There are currently 184,248 ESSA Pharma shares held short by investors – that's known as ESSA Pharma's "short interest". This figure is 13.5% up from 162,364 last month.

There are a few different ways that this level of interest in shorting ESSA Pharma shares can be evaluated.

ESSA Pharma's "short interest ratio" (SIR)

ESSA Pharma's "short interest ratio" (SIR) is the quantity of ESSA Pharma shares currently shorted divided by the average quantity of ESSA Pharma shares traded daily (recently around 219342.85714286). ESSA Pharma's SIR currently stands at 0.84. In other words for every 100,000 ESSA Pharma shares traded daily on the market, roughly 840 shares are currently held short.

However ESSA Pharma's short interest can also be evaluated against the total number of ESSA Pharma shares, or, against the total number of tradable ESSA Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ESSA Pharma's short interest could be expressed as 0% of the outstanding shares (for every 100,000 ESSA Pharma shares in existence, roughly 0 shares are currently held short) or 0.0057% of the tradable shares (for every 100,000 tradable ESSA Pharma shares, roughly 6 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ESSA Pharma.

Find out more about how you can short ESSA Pharma stock.

ESSA Pharma share dividends

We're not expecting ESSA Pharma to pay a dividend over the next 12 months.

Have ESSA Pharma's shares ever split?

ESSA Pharma's shares were split on a 1:20 basis on 24 April 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ESSA Pharma shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for ESSA Pharma shares which in turn could have impacted ESSA Pharma's share price.

ESSA Pharma share price volatility

Over the last 12 months, ESSA Pharma's shares have ranged in value from as little as $4.26 up to $32.647. A popular way to gauge a stock's volatility is its "beta".

EPIX.US volatility(beta: 1.68)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ESSA Pharma's is 1.6823. This would suggest that ESSA Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

ESSA Pharma overview

ESSA Pharma Inc. , a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site